![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 06, 2020 10:42:21 AM
• sterile collection container(s): standard cryo-vial(s) or specimen cup(s)
• sterile saline or phosphate buffered solution
• sterile scalpel
• packaging tape
PROCEDURE:
Tissue Collection
After the tumor is resected, and a portion of the tumor tissue is sent to the Pathology Department for
evaluation, collect all of the remaining tumor tissue (maximum amount possible - hopefully at least 3-5 grams), in the sterile environment of the Operating Room using the following steps. The more tumor tissue that is collected, the more doses of DCVax®-L that can potentially be made.
1. Place tumor tissue on a sterile surface in the Operating Room such as a Petri dish or autoclaved tray.
2. Rinse blood and debris from surface of tumor tissue using sterile saline or phosphate buffered solution. Remove all of the rinse solution from the tumor tissue before putting it into a collection container.
.
3. Place the rinsed tumor tissue in one of the following containers (listed in order of preference).
Do not put any preservative or other agent into the container with the tissue.
• Cryovial (multiple tubes may be used) • Specimen cup with screw cap
• Specimen cup with snap-on cap
4. Place the cap(s) on the collection container(s)/tube(s). Ensure each cap is secure.
5. Record the following information on each container/tube/specimen bag of tumor tissue:
• The words “Human Tumor”
• Patient’s Initials (1st character of given name, 1st character of middle name (if any*), and 1st character of surname). (*If there is no middle name, put a dash between the first and last initials as a placeholder). If there is more than one middle name, use only the initial of the first of those names).
• Patient’s Date of Birth (DOB) (arranged as follows: DD/MON/YY (where MON represents the first three (3) letters of the month
• Date of Surgery/Tissue Collection (arranged as follows: DD/MON/YY (where MON represents the first three (3) letters of the month
Tissue Freezing
1. The tissue should remain at ambient temperature for no more than 4 hours after resection, if possible.
2. Within 4 hours, place the labeled specimen container(s) in a freezer at -70 or -80 degrees C. If such a freezer is not immediately available, the specimen container(s) can be placed in a freezer at
-20° C or colder freezer to hold on a temporary basis while arrangements are made for storage in
a -70 or -80 degrees C freezer. Do not allow the tumor tissue to thaw when it is transferred.
3. Ideally, within a few months after the initial freezing, if the tumor tissue is still being stored and has not been used (e.g., to produce a treatment product), the tissue should be moved to a liquid nitrogen freezer
at -150° C or colder. Do not allow the tumor tissue to thaw when it is transferred.
If there are any questions please contact your patient liaison: Sue Goldman, Director Patient Affairs, NWBio sue@nwbio.com
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM